Dendritic cells loaded with CD44(+) CT-26 colon cell lysate evoke potent antitumor immune responses

Increasing evidence supports the concept that cancer stem cells (CSCs) are responsible for cancer progression and metastasis, therapy resistance and relapse. In addition to conventional therapies for colon cancer, the development of immunotherapies targeting cancer stem cells appears to be a promisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Changhao, Zhou, Ning, Zhao, Yuanyuan, Duan, Jinyue, Xu, Hao, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865088/
https://www.ncbi.nlm.nih.gov/pubmed/31788063
http://dx.doi.org/10.3892/ol.2019.10952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865088/
https://www.ncbi.nlm.nih.gov/pubmed/31788063
http://dx.doi.org/10.3892/ol.2019.10952

Ejemplares similares